AbbVie to Present at the Leerink Partners Global Healthcare Conference
Get Alerts ABBV Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.8%
EPS Growth %: +107.5%
Join SI Premium – FREE
A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.
Media: | Investors: |
Gabby Tarbert | Liz Shea |
(224) 244-0111 | (847) 935-2211 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-leerink-partners-global-healthcare-conference-302390547.html
SOURCE AbbVie
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- INOX SOLAR AMERICAS ANNOUNCES 767-MW PV MODULE SUPPLY AGREEMENT WITH LEADING U.S. SOLAR ENERGY DEVELOPER
- Hypershell Redefines Human Mobility with Halo, Flagship Full-Leg Exoskeleton Built for All-Terrain Mobility
- Deepdub Launches Phantom Z 3.4 Conversational: Multilingual Text-to-Speech Built to Survive Real Customers, Not Just Demos
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share